An ASO Journey: Leveraging AI to Tackle Rare Neurological Diseases
News
From Discovery to Delivery: Scaling AI Across the Value Chain
Servier’s Golden Ticket goes to Tinos Therapeutics to unlock the potential of epitranscriptomics in next-generation medicines
Listening to Patients: How Patient Advocacy Groups Help Shape Servier’s Neuroscience Research
A New Era in Oncology: A Conversation with Walid Kamoun on Four Years at Servier
Lessons Learned: Insights from Servier Leaders on International Women’s Day
Honoring Rare Disease Day with the KCNT1 Epilepsy Foundation
Innovation, Partnerships, and AI: A Conversation with Dale Porter
Servier Welcomes Peter Adamson as Global Head of Oncology Clinical Development
